MS primarily affects young adults and is more common in women. The prevalence continues to rise globally, including in aging ...

Although rarely used in psoriatic arthritis (PsA), combination targeted therapy (CTT) appears to have a safety profile ...

Temperature changes and pollution can have significant impacts on allergies, Gary Falcetano, PA-C, AE-C, US Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, explained in an ...

Access to gender-affirming surgery (GAS) was often blocked by barriers for transgender, nonbinary, and gender diverse (TGD) individuals looking to undergo the operation. A new analysis published in ...

Refat Rasul Srejon, MPH, says reducing opioid-related emergency department (ED) visits among young adults requires strategies like medication-assisted treatment and targeted outreach.

For patients with multiple myeloma who have undergone multiple lines of treatment and are refractory to common agents, new therapies offer remarkable hope. With 3 BCMA-targeted bispecific antibodies ...

This multicenter, prospective observational study is published in Frontiers in Clinical Diabetes and Healthcare. “Pre-treatment assessment of eating behavior patterns may help predict who will benefit ...

Researchers have found bariatric surgery to be more cost-effective for treating patients with obesity compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to new study ...

A higher burden of metabolic issues were found in people living with HIV in a study published in HIV Research & Clinical Practice. 1 Despite this increased burden, however, individuals living with HIV ...

The FDA's removal of REMS for CAR T-cell therapies enhances access for community oncology, paving the way for innovative treatments and improved patient outcomes.

Laxmi Patel discusses proposed Medicaid reforms in HR 1, including work rules, coverage limits, and state-level risks for ...

Overall, these data show the prognostic potential for 24 weeks of sotatercept therapy to improve the heart’s right ...